[HTML][HTML] Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?

O Iwaloye, PO Ottu, F Olawale, OO Babalola… - Informatics in Medicine …, 2023 - Elsevier
The escalating prevalence of cancer on a global scale, coupled with the inadequacies of
present-day therapies and the emergence of drug-resistant cancer strains, has necessitated …

Pyrrolo [2, 3-d] pyrimidines as potential kinase inhibitors in cancer drug discovery: A critical review

MS Madhurya, V Thakur, S Dastari, N Shankaraiah - Bioorganic Chemistry, 2024 - Elsevier
Abstract Pyrrolo [2, 3-d] pyrimidine-based kinase inhibitors have emerged as an important
class of targeted therapeutics to combat various types of cancer. The distinctive structural …

Identification of selective cyclin-dependent kinase 2 inhibitor from the library of pyrrolone-fused benzosuberene compounds: an in silico exploration

R Singh, VK Bhardwaj, J Sharma, P Das… - Journal of …, 2022 - Taylor & Francis
The over-expression of cyclin-dependent kinase 2 is related to multiple cancers, which has
led them to be a widely researched topic for nearly two decades. The prime focus of the …

Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs

VK Bhardwaj, R Singh, P Das, R Purohit - Computers in Biology and …, 2021 - Elsevier
Abstract Background The main protease (Mpro) of SARS-CoV-2 is involved in the
processing of vital polypeptides required for viral genome replication and transcription and …

Identification of 11β-HSD1 inhibitors through enhanced sampling methods

R Singh, VK Bhardwaj, P Das, R Purohit - Chemical Communications, 2022 - pubs.rsc.org
Aminoarylbenzosuberene (AAB) molecules were chosen for in silico analysis to develop
effective and more competent 11β-hydroxysteroid dehydrogenase (11β-HSD1) protein …

Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals

LY Sun, C Chen, J Su, JQ Li, Z Jiang, H Gao… - Bioorganic …, 2021 - Elsevier
The emerging COVID-19 pandemic caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has raised a global catastrophe. To date, there is no specific …

Structure‐based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases

S Anwar, S Khan, A Shamsi, F Anjum… - Journal of cellular …, 2021 - Wiley Online Library
MAP/microtubule affinity‐regulating kinase 4 (MARK4) is a member of serine/threonine
kinase family and considered an attractive drug target for many diseases. Screening of …

Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study

H Qayoom, U Mehraj, S Sofi, S Aisha, A Almilaibary… - Medical oncology, 2022 - Springer
The CDKs are known to play a critical role in cell cycle regulation process. Among the
different groups of CDKs, CDK4 overexpression/hyperactivation is found to be present in …

Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2

VK Singh, H Chaurasia, P Kumari, A Som… - Journal of …, 2022 - Taylor & Francis
A new series of quinoline derivatives has been designed and synthesized as probable
protease inhibitors (PIs) against severe acute respiratory syndrome coronavirus 2. In silico …

High throughput virtual screening and molecular dynamics simulation analysis of phytomolecules against BfmR of Acinetobacter baumannii: anti-virulent drug …

KB Lokhande, SV Pawar, S Madkaiker… - Journal of …, 2023 - Taylor & Francis
Acinetobacter baumannii is a notorious multidrug resistant bacterium responsible for several
hospital acquired infections assisted by its capacity to develop biofilms. A. baumannii BfmR …